BioScience Ventures, Inc.

Contact Information:

David A. Palella, Founder & President
2640 Del Mar Heights Road, Suite 267
Del Mar, California 92014
USA
Email: Please send email to:
Phone: 619-793-0741
Fax: 619-793-0742


BioScience Ventures, Inc. is a San Diego, California-based consulting firm specializing in global strategic alliances in the biopharmaceutical, diagnostics and biotech/biomedical fields.


Current Clients:

Kaken Pharmaceutical Co., Ltd.
Tokyo, Japan
BioScience Ventures, Inc. assists Kaken with in-licensing of novel therapeutic compounds for autoimmune, bone, rheumatic, orthopaedic, cardiovascular, dermatological and ophthalmic diseases (as well as animal health care products) from U.S., Canadian, European and Australian biopharmaceutical companies. In 1993 BioScience Ventures initiated and facilitated a confidential two-year funded research agreement between Kaken and a U.S. research institute for the rational design of a peptidomimetic therapeutic compound. Kaken is a US$ 750 million mid-sized fully-integrated pharmaceutical company.

Nissin Food Products Co., Ltd.
Osaka, Japan
BioScience Ventures, Inc. seeks in-licensing opportunties and monitors worldwide developments for Nissin in the areas of: (1) anti-HIV therapeutics and HIV diagnostic kits; and (2) technologies for enhancement of monoclonal antibody-based drugs. Nissin is a US$ 3 billion diversified food company with a pharmaceutical subsidiary (MECT Corp.) and pharmaceutical research institute (in Kusatsu).

Iwaki & Co.
Tokyo, Japan
BioScience Ventures seeks new import opportunities (to Japan) for Iwaki from North American and European biotech companies with exportable reagents, research kits and biotech equipment. Iwaki & Co. is a US$ 600 million trading company specializing in import/export of pharmaceutical intermediates, fine chemicals and biotech products.

Asahi Glass Co., Ltd.
Yokohama, Japan
BioScience Ventures, Inc. identifies and qualifies North American and European distributors and major licensees for Asahi's novel yeast expression system, ASPEX-94.

Other Current Clients:

MediLite Diagnostika, Inc.
Santee, California
BioScience Ventures, Inc. facilitates international strategic alliances for MediLite in the areas of ultra-sensitive enzyme-mediated chemiluminescent immunoassays; enzyme-based diagnostic kits for neonate testing; and ultra-sensitive DNA probes.

Canadian Trade Office/Canadian Consulate
San Diego, California
BioScience Ventures, Inc. advises on strategies and tactics to increase trade and investment between Southern California and Canadian biotech and high-tech companies.

Multi-client Studies/Directories

1995-1996 Molecular Diversity Directory (154 pages)
Published August 1995
Price: US$ 3,995.oo (subject to change without notice)
A comprehensive, up-to-date guide to over 100 prominent companies and researchers in the U.S. and Europe with full contact information. Focuses on small-molecule combinatorial chemistry, high through-put screening and robotic synthesis. Also covers oligonucleotides, peptides and natural product libraries.

High-speed Gene Sequencing & Localization: Directory of Companies & Organizations (152 pages)
Published November 1995
Price: US$ 3,995.oo (subject to change without notice)
A comprehensive, up-to-date guide to more than 80 entities from small lesser-known bioventure companies to large multinationals like Merck & SmithKline Beecham, as well as university-based sequencing labs and national genome centers. Focuses on therapeutic/diagnostic efforts based on human and mouse genome sequencing. Equipment, software and reagent companies are also featured.

For additional information ...

about any of our clients, please contact David A. Palella. For more details about, and ordering information for, our publications, please see our "Brochure" page and "Order Form."



Return to Home Page ...